Recurrent IGLL5 mutations have been identified in CLL, linked to canonical activation induced-cytidine deaminase (AID) activity with a mutation pattern clustering around the transcription start site within the first intron29. Here, IGLL5 is linked to B-cell chronic lymphocytic leukemia.